Levente Erdos, MD
Allergy & Immunology · Peoria, AZNPI 1659473197
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 99 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 22.3% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for allergy & immunology clinicians in AZ, where the typical reported total is $2,389.
Across 99 payments — averaging $21.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$470
- Novartis$214
- GSK$212
- AstraZeneca$185
- Pharming Healthcare, Inc.$147
- Genentech USA, Inc.$127
- plus $754 from 16 others
What the payments were for
- Food & beverage$2,101100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 22 | $470 |
| Novartis | 9 | $214 |
| GSK | 11 | $212 |
| AstraZeneca | 12 | $185 |
| Pharming Healthcare, Inc. | 6 | $147 |
| Genentech USA, Inc. | 7 | $127 |
| Incyte Corporation | 5 | $111 |
| Grifols USA, LLC | 2 | $104 |
| Regeneron Healthcare Solutions, Inc. | 5 | $91 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $78 |
| Pfizer | 3 | $65 |
| Blueprint Medicines Corporation | 2 | $52 |
| Organon | 2 | $42 |
| Covis Pharma GmbH | 1 | $35 |
| Shire North American Group Inc | 2 | $34 |
| CSL Behring | 1 | $33 |
| Phadia US Inc. | 1 | $27 |
| Boehringer Ingelheim | 1 | $26 |
| Dermavant Sciences, Inc. | 1 | $24 |
| AbbVie | 1 | $14 |
| Bio Products Laboratory USA, Inc. | 1 | $8 |
| ADMA Biomanufacturing LLC | 1 | $7 |
How this compares
$2,109 in reported general payments places this provider in the 45th percentile of 90 allergy & immunology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 35 | $135,918 |
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 24 | $79,797 |
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 29 | $75,956 |
| Dupixent SyringeDupilumab | 19 | $71,331 |
| XolairOmalizumab | 32 | $69,298 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 73 | $57,958 |
| Breo ElliptaFluticasone/Vilanterol | 78 | $44,868 |
| Spiriva RespimatTiotropium Bromide | 38 | $27,156 |
| Arnuity ElliptaFluticasone Furoate | 65 | $17,524 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 20 | $15,590 |
| Azelastine Hcl | 286 | $9,441 |
| Advair HfaFluticasone Propion/Salmeterol | 13 | $7,470 |
| Epinephrine | 29 | $6,087 |
| SymbicortBudesonide/Formoterol Fumarate | 12 | $5,790 |
| Ipratropium Bromide | 149 | $5,444 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $212 | $120,350216 claims |
| Grifols USA, LLCGamunex-C | $104 | $79,79724 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Gammagard Liquid | $78 | $75,95629 claims |
| Boehringer IngelheimSpiriva Respimat | $26 | $27,15638 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $185 | $21,38032 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 90 allergy & immunology providers in Arizona.
Other allergy & immunology in Peoria
- Gilbert OrtegaPeoria$30K
- Ronald MittelPeoria$23K
- Mark RosePeoria$21K
- Ryan CasperPeoria$20K
- Ronald JorgensenPeoria$19K
- Kevin BoeselPeoria$15K
- Eiza ChingPeoria$12K
- Christine PrattPeoria$7K
- Gregory CowanPeoria$5K
- Michael ManningScottsdale$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.